CD8A and cancer: Unfortunately, cancer and immune cells express checkpoint ligands such as programmed death-ligand 1 (PD-L1) and CTL-associated antigen 4 (CTLA-4), which bind to CD8+ T cells and repress their T-cell receptor (TCR) signaling, proliferation, and motility [62,74,75].